WGb-0302

· Sichuan University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WGb-0302, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Study on the Treatment of Recurrent and Refractory Hematological Malignancies With WGb-0302 Injection [EARLY_Phase 1]

See pricing